AUG 11, 2026 · OBSERVATIONAL STUDY
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
ClinicalTrials.gov
This is a recruiting observational study designed to develop and validate a biomarker panel; no results are reported in this registry record.
Reported
Planned enrollment250
Primary outcome: Time-to-Event An…up to 3 years post-transplant
Primary outcome: Time-to-Event An…up to 3 years post-transplant